57.82

2.88% 1.62

Pre-market: 56.55 -1.27 -2.20%

Hims Hers Health Inc (HIMS)

Overview News Price History Option Chain Financials Why HIMS Down? Discussions Forecast

Hims Hers Health Inc stock is traded at $57.82, with a volume of 36.13M. It is up +2.88% in the last 24 hours and up +37.08% over the past month. Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

Previous Close:

$56.20

Open:

$56.23

24h Volume:

36.13M

Relative Volume:

1.04

Market Cap:

$12.58B

Revenue:

$1.78B

Net Income/Loss:

$164.40M

P/E Ratio:

83.80

EPS:

0.69

Net Cash Flow:

$236.51M

1W Performance:

+4.18%

1M Performance:

+37.08%

6M Performance:

+70.66%

1Y Performance:

+241.73%

1-Day Range:

$56.17

$59.36

1-Week Range:

$48.69

$59.36

52-Week Range:

$15.73

$72.98

Hims Hers Health Inc Stock (HIMS) Company Profile

Name

Hims Hers Health Inc

Sector

Healthcare (1154)

Industry

Drug Manufacturers - Specialty & Generic (83)

Phone

415-851-0195

Address

2269 CHESTNUT ST, SAN FRANCISCO

Employee

1,637

Twitter

Next Earnings Date

2025-02-24

Latest SEC Filings

HIMS's Discussions on Twitter

Compare HIMS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HIMS Hims Hers Health Inc	57.82	12.70B	1.78B	164.40M	236.51M	0.69
PG Procter Gamble Co	156.04	368.21B	84.28B	16.07B	14.05B	6.51
UL Unilever Plc Adr	61.20	150.69B	64.99B	6.71B	6.53B	2.4495
CL Colgate Palmolive Co	81.17	65.89B	20.00B	3.05B	3.37B	3.56
KMB Kimberly Clark Corp	124.62	41.64B	18.88B	2.38B	2.10B	7.26
KVUE Kenvue Inc	18.34	34.74B	15.14B	1.42B	1.63B	0.74

Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-23-25	Downgrade	Needham	Buy → Hold
Jun-04-25	Reiterated	Needham	Buy
Apr-29-25	Downgrade	TD Cowen	Buy → Hold
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-10-25	Downgrade	Citigroup	Neutral → Sell
Jan-07-25	Initiated	BTIG Research	Buy
Dec-17-24	Initiated	Morgan Stanley	Overweight
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral
Apr-16-24	Downgrade	Jefferies	Buy → Hold
Apr-10-24	Initiated	Canaccord Genuity	Buy
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform
Feb-26-24	Initiated	Leerink Partners	Market Perform
Dec-07-23	Initiated	Imperial Capital	In-line
Jul-28-23	Initiated	TD Cowen	Outperform
Apr-11-23	Initiated	Robert W. Baird	Neutral
Feb-09-23	Upgrade	Jefferies	Hold → Buy
Nov-08-22	Upgrade	BofA Securities	Neutral → Buy
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform
Oct-17-22	Downgrade	Piper Sandler	Overweight → Neutral
Sep-07-22	Initiated	Truist	Hold
Jul-15-22	Initiated	SVB Leerink	Underperform
Apr-14-22	Initiated	Guggenheim	Buy
Apr-01-22	Resumed	Credit Suisse	Outperform
Mar-10-22	Initiated	Deutsche Bank	Hold
Dec-02-21	Initiated	Jefferies	Hold
Nov-11-21	Upgrade	Piper Sandler	Neutral → Overweight
Jul-06-21	Initiated	BofA Securities	Neutral
May-20-21	Upgrade	Credit Suisse	Neutral → Outperform
Apr-21-21	Initiated	Truist	Hold
Mar-09-21	Initiated	Credit Suisse	Neutral
Mar-02-21	Upgrade	Citigroup	Neutral → Buy
Feb-17-21	Initiated	Citigroup	Neutral
Feb-12-21	Initiated	Piper Sandler	Neutral
Feb-08-21	Initiated	Tigress Financial	Buy

View All

Hims Hers Health Inc Stock (HIMS) Latest News

Sep 21, 2025

Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy - MSN

Sep 21, 2025

Abacus FCF Advisors LLC Lowers Stake in Hims & Hers Health, Inc. $HIMS - MarketBeat

Sep 21, 2025

TTP Investments Inc. Takes $249,000 Position in Hims & Hers Health, Inc. $HIMS - MarketBeat

Sep 21, 2025

Online pharmacies are still selling cheap copycat Ozempic and other weight loss drugs, despite new FDA rules - Business Insider

Sep 21, 2025

Aug PostEarnings: Can Hims Hers Health Inc maintain sales growth2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - khodrobank.com

Sep 21, 2025

Sep 20, 2025

Insider Selling: Hims & Hers Health (NYSE:HIMS) Insider Sells 2,637 Shares of Stock - MarketBeat

Sep 20, 2025

Hims & Hers Health (NYSE:HIMS) CEO Sells $3,292,612.70 in Stock - MarketBeat

Sep 20, 2025

Hims & Hers Health (NYSE:HIMS) Insider Patrick Harrison Carroll Sells 10,021 Shares - MarketBeat

Sep 20, 2025

Hims & Hers Health (NYSE:HIMS) Insider Sells $424,705.00 in Stock - MarketBeat

Sep 20, 2025

Strs Ohio Buys New Position in Hims & Hers Health, Inc. $HIMS - MarketBeat

Sep 20, 2025

Rep. Lisa C. McClain Purchases Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat

Sep 20, 2025

Sep 19, 2025

Insider Sell: Soleil Boughton Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus

Sep 19, 2025

Belpointe Asset Management LLC Has $225,000 Stake in Hims & Hers Health, Inc. $HIMS - MarketBeat

Sep 19, 2025

Oscar Health Set For HIMS-Style Moonshot? Shorts Could Burn As ACA Buzz Builds - inkl

Sep 19, 2025

Telehealth Stock Looks Primed for a Short Squeeze - Schaeffer's Investment Research

Sep 19, 2025

Aug Mood: Should I set a stop loss on Hims Hers Health IncJuly 2025 Action & Verified Technical Trade Signals - khodrobank.com

Sep 19, 2025

The Weight-Loss Craze Boosted The $186 Billion Telehealth Industry. What It Means For Investors. - inkl

Sep 19, 2025

Revenues Tell The Story For Hims & Hers Health, Inc. (NYSE:HIMS) As Its Stock Soars 33% - 富途牛牛

Sep 19, 2025

Voya Investment Management LLC Sells 127,512 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat

Sep 19, 2025

Intech Investment Management LLC Increases Position in Hims & Hers Health, Inc. $HIMS - MarketBeat

Sep 19, 2025

Sep 18, 2025

Insider Selling: Hims & Hers Health (NYSE:HIMS) Insider Sells 4,150 Shares of Stock - MarketBeat

Sep 18, 2025

Hims & Hers Health (NYSE:HIMS) CEO Andrew Dudum Sells 128,127 Shares - MarketBeat

Sep 18, 2025

Hims & Hers Health (NYSE:HIMS) CFO Oluyemi Okupe Sells 145,000 Shares - MarketBeat

Sep 18, 2025

Hims & Hers Health Inc. Class A (HIMS) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade

Sep 18, 2025

Emcor Stock, Hims & Hers, SiTime Among New Stocks On IBD Watchlists - Investor's Business Daily

Sep 18, 2025

Hims & Hers Health: Bumpy Ride Will End - Seeking Alpha

Sep 18, 2025

Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs - Benzinga

Sep 18, 2025

Hims & Hers Is An Interesting Story, But Not The One I Signed Up ForDowngrade - Seeking Alpha

Sep 18, 2025

City Center Advisors LLC Invests $376,000 in Hims & Hers Health, Inc. $HIMS - MarketBeat

Sep 18, 2025

FDA Hims And Hers Misleading Claims Warning - Effingham Radio

Sep 18, 2025

Lake Hills Wealth Management LLC Makes New Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat

Sep 18, 2025

Sep 17, 2025

Hims & Hers Health (NYSE:HIMS) Stock Price Down 8.4%What's Next? - MarketBeat

Sep 17, 2025

FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes - PBS

Sep 17, 2025

Why Novo Nordisk Stock Popped Today - The Motley Fool

Sep 17, 2025

FDA Cracks Down on Hims, Other Telehealth Companies Over Drug Ads - WFMZ.com

Sep 17, 2025

In a first, FDA calls out Hims and other telehealth companies for GLP-1 advertising - Endpoints News

Sep 17, 2025

Should Investors Rethink Hims & Hers After FDA Flags Super Bowl Ad and Shares Double in 2025? - Yahoo Finance

Sep 17, 2025